Rabies is a viral disease that causes inflammation of the brain in humans and other mammals. Early symptoms can include fever and tingling at the site of exposure. These symptoms are followed by one or more of the following symptoms: violent movements, uncontrolled excitement, fear of water, an inability to move parts of the body, confusion, and loss of consciousness. Once symptoms appear, the result is nearly always death. The time period between contracting the disease and the start of symptoms is usually one to three months, but can vary from less than one week to more than one year. The time depends on the distance the virus must travel along peripheral nerves to reach the central nervous system.
This report contains market size and forecasts of Rabies Diagnostics in Global, including the following market information:
Global Rabies Diagnostics Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Rabies Diagnostics market was valued at 1789.7 million in 2021 and is projected to reach US$ 2111.8 million by 2028, at a CAGR of 2.4% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Enzyme-Linked Immunosorbent Assay (ELISA) Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Rabies Diagnostics include Bio-Rad Laboratories, Merck, Thermo Fisher, Roche, BioMerieux, QIAGEN, Agilent, Creative Diagnostics and Techne, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Rabies Diagnostics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Rabies Diagnostics Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Rabies Diagnostics Market Segment Percentages, by Type, 2021 (%)
Enzyme-Linked Immunosorbent Assay (ELISA)
Polymerase Chain Reaction (PCR) Assay
Others
Global Rabies Diagnostics Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Rabies Diagnostics Market Segment Percentages, by Application, 2021 (%)
Hospitals
Diagnostic Centers
Public Health Labs
Home Care Setting
Global Rabies Diagnostics Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Rabies Diagnostics Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Rabies Diagnostics revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Rabies Diagnostics revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Bio-Rad Laboratories
Merck
Thermo Fisher
Roche
BioMerieux
QIAGEN
Agilent
Creative Diagnostics
Techne
Fluidigm
Abbexa Ltd
BioNote, Inc
Norgen Biotek Corp
Aviva Systems Biology
Demeditec Diagnostics GmbH
Express Biotech International